IFPMA Creates Pediatric Task Force to Help Improve Availability of Medicines and Vaccines for Children

First Page		Document Content
Date: 2013-06-30 20:56:19 Pharmacology Pharmaceutical industry Clinical research IFPMA World Anti-Doping Agency Japan Pharmaceutical Manufacturers Association Use of performance-enhancing drugs in sport Pharmaceutical Research and Manufacturers of America European Federation of Pharmaceutical Industries and Associations Pharmaceutical sciences Drugs in sport Sports		IFPMA Creates Pediatric Task Force to Help Improve Availability of Medicines and Vaccines for Children Add to Reading List Source URL: www.jpma.or.jp Download Document from Source Website File Size: 78,27 KB Share Document on Facebook

	The Pharmaceutical Industry in Figures Key Data • 2015 THE PHARMACEUTICAL INDUSTRY: A KEY ASSET DocID: 1gpaV - View Document
	About Us Ø JPMA (Japan Pharmaceu0cal Manufacturers Associa0on) is a voluntary associa0on comprising 71 research-‐oriented pharmaceu0cal companies. DocID: 1at8P - View Document
	Basic Attitude of the Japan Pharmaceutical Manufacturers Association towards the Convention on Biological Diversity (CBD) The Japan Pharmaceutical Manufacturers Association (JPMA) has put many ideas into practice to deli DocID: 196LX - View Document
	Global pharmaceutical industry calls for broad-based cooperation to fight online sales of counterfeit medicines around the world • • Four major pharmaceutical associations issue joint policy statement to crack down DocID: 18PNk - View Document
	Supplement to the Guidance for Electronic Data Capture in Clinical Trials January 10, 2012 Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association DocID: 18JdV - View Document